Filing summary
Entity and period: The supplied filing is FTAC Emerald Acquisition Corp.’s Form 10-K for the fiscal year ended December 31, 2021, not a filing for Fold Holdings, Inc. The company is a SPAC and had no operating business at year-end. The filing was signed March 22, 2022.
Business context
FTAC Emerald was formed to identify and complete a business combination. It said it would focus primarily on businesses with social, financial and environmental value, including clean energy, water sustainability, agricultural technology, shared-economy software and next-generation mobility, but could pursue other sectors. At December 31, 2021, it had selected no target and had not begun substantive discussions with one.
Financial performance and position
- Revenue: No operating revenue. The company did not expect operating revenue before completing a business combination.
- Net loss: $99,988 from inception on February 19, 2021 through December 31, 2021, comprising $100,518 of formation and operating costs, partly offset by $530 of trust-account interest. Basic and diluted loss per share was $0.02 for each share class.
- Cash flow: Net cash used in operating activities was $593,448; investing activities used $222.2 million, primarily for the trust-account deposit; financing activities provided $224.0 million. Year-end cash outside the trust was $1.23 million.
- Assets and liquidity: Total assets were $225.2 million, including $222.2 million in trust investments and $1.64 million in current assets. Working capital was $1.55 million. The filing reports $10.10 per public share in trust at year-end.
- Liabilities and debt: Total liabilities were $8.95 million, including $7.7 million of deferred underwriting discount and $1.16 million of deferred advisory fee. The sponsor promissory note was repaid and terminated in December; no working-capital loans were outstanding at year-end. The company reported no long-term debt obligations.
- Equity presentation: Stockholders’ deficit was $5.98 million. Public shares subject to redemption were classified as temporary equity, resulting in negative stockholders’ equity.
- Margins: Not meaningful because the company had no operating revenue.
Material changes and subsequent events
The company completed an IPO of 22.0 million units on December 20, 2021, raising $220.0 million gross. In January 2022, the underwriter partially exercised its over-allotment option, adding 2.87 million units and $28.69 million gross; the sponsor also bought 86,081 additional placement units. Following those transactions, the filing says $251.18 million was held in trust. The post-year-end proceeds should not be confused with the $222.2 million trust balance reported on the December 31 audited balance sheet.
The financial statements received an unqualified audit opinion. Management concluded disclosure controls were effective at December 31, 2021; no auditor attestation or management report on internal control over financial reporting was included, citing the newly public company transition period.
Outlook, risks and unusual items
- The company had no operating results or identified acquisition target, so the filing provides no operating guidance or target-specific outlook. Management believed available working capital and borrowing capacity would cover needs through the earlier of a business combination or one year from the filing, but sponsor and management loans were not committed.
- The SPAC had until June 20, 2023 to complete a business combination, extendable to September 20, 2023 if it had entered into a qualifying agreement by the initial deadline. If unsuccessful, it generally must redeem public shares from trust and liquidate; warrants would expire worthless.
- Only $1.23 million of cash was outside the trust at year-end. Additional transaction funding could require sponsor loans, outside financing, equity issuance or debt; none was assured. Up to $2.0 million of qualifying working-capital loans could be converted into units at the lender’s option.
- Key risks include intense competition for targets, redemptions reducing deal cash, possible dilution and debt, third-party claims against trust assets, and the possibility that the sponsor cannot meet its trust indemnity. The filing notes the sponsor’s founder shares were acquired for a nominal $25,000, creating an incentive to complete a transaction that may differ from public shareholders’ interests.
- Potential conflicts include management’s roles at other SPACs and existing fiduciary or contractual obligations that may require presenting opportunities to other entities first. Cohen & Company Capital Markets (CCM), affiliated with the Chairman’s family and with investment vehicles passively invested in the sponsor, received IPO-related fees and may earn a business-combination advisory fee.
- COVID-19 could affect the target search and financing, with the specific impact described as indeterminable. The filing also said the effects of Russia’s 2022 invasion of Ukraine and related sanctions were not determinable.
- Other notable terms include a $30,000 monthly sponsor administrative-services fee, a 3.5% deferred underwriting discount payable only on a completed combination, and warrants exercisable at $11.50 per share, subject to stated terms and adjustments.
Important facts for investors to verify
- Confirm the issuer identity: the supplied document is for FTAC Emerald Acquisition Corp., not Fold Holdings, Inc.
- Reconcile the year-end trust balance ($222.2 million) with the later reported post-over-allotment trust balance ($251.18 million) and distinguish year-end amounts from January 2022 events.
- Review the trust redemption provisions, completion deadline and any later filings regarding a target, extension, financing or liquidation.
- Assess the sponsor’s ability to honor its trust indemnity and the impact of redemptions, dilution, deferred fees and related-party arrangements on value available to public shareholders.
- Review the complete audited financial statements, warrant terms and subsequent-event disclosures before relying on the summary figures.